Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
D000328:Adult; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D014268:Trifluoperazine / Q000627:therapeutic use
D009539:Nicotinic Acids; D014268:Trifluoperazine; D002746:Chlorpromazine